Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Sny crawled date : 2021 - 03 - 15 save search
Bullous Pemphigoid Market is Expected to Grow With a CAGR of 16.27% for the Study Period of 2018-2030, says DelveInsight
Published: 2021-03-15 (Crawled : 17:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
Sanofi and Regeneron Halt Cervical Cancer Trial Early Due to Dazzling Results...
Published: 2021-03-15 (Crawled : 16:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
results cancer trial
Global Meningococcal Vaccines Disease Coverage Forecast and Market Analysis to 2024: Assessment, Future Trends, Unmet Needs, Marketed Vaccines
Published: 2021-03-15 (Crawled : 15:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
disease vaccine
Sanofi and Regeneron Halt Cervical Cancer Trial Early Due to Dazzling Results, Plan to Submit to ...
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
results cancer trial
Clinical Catch-Up: March 8-12
Published: 2021-03-15 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
Aiforia appoints Swedbank as lead advisor to explore financing options
Published: 2021-03-15 (Crawled : 09:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
Phase 3 trial of Libtayo® (cemiplimab) monotherapy in advanced cervical cancer stopped early for positive result on overall survival
Published: 2021-03-15 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.33%
H: 2.47%
C: 2.31%
positive therapy cancer phase 3 trial
Danone: New governance at Danone; Emmanuel Faber steps down as Chairman and CEO Gilles Schnepp appointed non-executive Chairman
Published: 2021-03-15 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
ceo
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.